Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2569008-99-5
2. Prifetrastat
3. Pf-07248144
4. Prifetrastat (usan)
5. Prifetrastat [usan]
6. Prifetrastat [inn]
7. Gn6du4ze30
8. Orb1982278
9. Chembl6068620
10. Schembl22802427
11. Schembl29490368
12. Gtpl14088
13. Bdbm730788
14. Ex-a9009
15. 2-methoxy-n-[4-methoxy-6-(pyrazol-1-ylmethyl)-1,2-benzoxazol-3-yl]benzenesulfonamide
16. Example 34 [wo2020254946]
17. Hy-153444
18. Cs-0775007
19. Pf07248144
20. D12983
21. H41429
22. Us20250122182, Example 45, Wo2020/254946
23. 2-methoxy-n-[4-methoxy-6-(1h-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]benzenesulfonamide
24. N-(6-((1h-pyrazol-1-yl)methyl)-4-methoxybenzo[d]isoxazol-3-yl)-2-methoxybenzenesulfonamide
25. 2-methoxy-n-{4-methoxy-6-[(1h-pyrazol-1-yl)methyl]-1,2-benzoxazol-3-yl}benzene-1-sulfonamide
26. Benzenesulfonamide, 2-methoxy-n-[4-methoxy-6-(1h-pyrazol-1-ylmethyl)-1,2-benzisoxazol-3-yl]-
| Molecular Weight | 414.4 g/mol |
|---|---|
| Molecular Formula | C19H18N4O5S |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 117 |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 645 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
99
PharmaCompass offers a list of Kat6-IN-1 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Kat6-IN-1 manufacturer or Kat6-IN-1 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Kat6-IN-1 manufacturer or Kat6-IN-1 supplier.
A Kat6-IN-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Kat6-IN-1, including repackagers and relabelers. The FDA regulates Kat6-IN-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Kat6-IN-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Kat6-IN-1 supplier is an individual or a company that provides Kat6-IN-1 active pharmaceutical ingredient (API) or Kat6-IN-1 finished formulations upon request. The Kat6-IN-1 suppliers may include Kat6-IN-1 API manufacturers, exporters, distributors and traders.
Kat6-IN-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Kat6-IN-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Kat6-IN-1 GMP manufacturer or Kat6-IN-1 GMP API supplier for your needs.
A Kat6-IN-1 CoA (Certificate of Analysis) is a formal document that attests to Kat6-IN-1's compliance with Kat6-IN-1 specifications and serves as a tool for batch-level quality control.
Kat6-IN-1 CoA mostly includes findings from lab analyses of a specific batch. For each Kat6-IN-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Kat6-IN-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Kat6-IN-1 EP), Kat6-IN-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Kat6-IN-1 USP).
